Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.
| Website: | www.herontx.com |
| Email: | info@herontx.com |
| Main Phone: | +1 858 251-4400 |
| Address: | 4242 Campus Point Court |
| Address 2: | Suite 200 |
| State: | CA |
| City / Town: | San Diego |
| Country: | USA |
| Postal Code: | 92121 |
| Exchange: | NSC |
| CEO: | Barry D. Quart |
| Employees: | 145 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 32.70 | Change $ 1.05 | Change % 3.32 | Tick N/A |
| Bid 31.95 | Bid Size 300.00 | Ask 33.75 | Ask Size 1,500.00 |
| Open 31.70 | High 32.80 | Low 31.20 | Prev Close 31.65 |
| Last Trade | Volume 2 mi | 52 Wk Hi 42.90 | 52 Wk Low 14.40 |
| Market Cap 2.5 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 77,734,284.00 | EPS (TTM) -3.22 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 5 | 10 |
| Number of Buys | 3 | 6 |
| Number of Sells | 2 | 4 |
| Net Activity | 192308 | 192844 |
| Last 10 Buys | Shares |
|---|---|
| Kevin C. Tang | 1,000 |
| John W. Poyhonen | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Kevin C. Tang | 1,000 |
| Barry D. Quart | 1,000 |
| Barry D. Quart | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Kimberly J. Manhard | 1,000 |
| Barry D. Quart | 1,000 |
| Barry D. Quart | 1,000 |
| Kimberly J. Manhard | 1,000 |
| Kimberly J. Manhard | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Robert H. Rosen | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 56 | 56 | 56 | 56 |
| Low Target Price Estimate | 30 | 30 | 30 | 30 |
| Mean Target Price Estimate | 39.91 | 39.91 | 39.91 | 39.91 |
| Standard Deviation | 9.01 | 9.01 | 9.01 | 9.01 |
| Date of Most Recent Estimate | 05/22/18 | 05/22/18 | 05/22/18 | 05/22/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 83 | 2018-05-10 |
| 8-K | Report of unscheduled material events or corporate changes. | 9 | 2018-05-10 |
| DEFA14A | Additional proxy soliciting materials - definitive | 3 | 2018-04-30 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 56 | 2018-04-30 |
| PRE 14A | Preliminary proxy statement providing notification matters to be brought to a vote | 56 | 2018-04-19 |
| 8-K | Report of unscheduled material events or corporate changes. | 57 | 2018-04-03 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-02 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 45 | 2018-03-30 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 44 | 2018-03-28 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-03-19 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 8 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.09 | 1.09 | 1.09 | 1.11 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
